TJ Garrigan, a non-lawyer, provides strategic policy advice to life sciences companies on key issues including drug pricing and Inflation Reduction Act (IRA) implementation, pharmacy benefit managers (PBMs), and the 340B program.
TJ joined the firm after having served as Deputy Director for the Division of Policy at the Centers for Medicare & Medicaid Services (CMS). At CMS, he was responsible for policy development for the Medicare Drug Price Negotiation and Medicare Inflation Rebate programs created by the IRA. He served as a member of the leadership team for the Medicare Drug Rebate and Negotiations Group which was created after passage of the IRA. TJ oversaw the drafting, editing, briefing, and approval of policy documents for the programs, including guidances, rules, and other technical communications. He advised group leadership, agency leadership, and political policy officials on various policy recommendations and decisions.
Prior to his role at CMS, TJ was Director for Policy and Regulatory Affairs at CVS Health and served as lead enterprise-wide policy staffer on a variety of issues, including drug pricing and competition, drug supply chain, health IT, privacy, value-based payments, and price transparency. Prior to CVS, TJ served as Director of Policy at the Association for Accessible Medicines (previously the Generic Pharmaceutical Association) where he was
Back
